The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
The Fidelity MSCI Health Care Index ETF (NYSEMKT:FHLC) provides broad healthcare exposure at a fraction of the cost of the State Street SPDR S&P Pharmaceuticals ETF (NYSEMKT:XPH), which targets a specific industry niche.
Investors seeking healthcare exposure must choose between broad sector coverage and targeted industry plays. While both funds operate within the same universe, they vary significantly in cost, diversification, and recent momentum. This comparison breaks down how these two popular ETFs navigate the medical landscape.
Beta measures price volatility relative to the S&P 500; beta is calculated from monthly returns over the available fund history (up to five years). The 1-yr return represents total return over the trailing 12 months. Dividend yield is the trailing-12-month distribution yield.
Cost-conscious investors may prefer the Fidelity fund, as its 0.08% expense ratio is significantly lower than the 0.35% charged by the SPDR fund. Additionally, the Fidelity fund offers a notably higher payout for income-focused portfolios.